No Detail Found!

Insulin-like growth factor-I signaling plays a pivotal role in the development of oral premalignant lesions in patients with diabetes mellitus

Author(s)
Sidra Aslam Department of Oral Biology, University of Health Sciences, Lahore, Pakistan
Sarah Ghafoor Department of Oral Biology, University of Health Sciences, Lahore, Pakistan.
Abstract
Diabetes mellitus is a disorder of the metabolic system that is diagnosed by hyperglycemia and glucose intolerance. Diabetic patients are frequently prone to developing oral health complications, such as being at a higher risk for developing oral precancerous conditions, like lichen planus, leukoplakia, and erythroplakia. Insulin-like growth factor-I (IGF-I) is a peptide hormone with a structure similar to insulin and belongs to the family of growth factors that play a vital role in the development of embryonic, postembryonic, and normal physiological functions of the human body. IGF-I, through autophosphorylation of its receptor, activates the mitogen-activated protein kinases pathway that leads to the expression of IGF-I hormone. In oral premalignant conditions, like lichen planus, submucous fibrosis, leukoplakia, and erythroplakia, the levels of the IGF-I hormone are increased. Subsequently, IGF-I can be used as a marker for early detection of malignancy in oral premalignant lesions.
Publication Details
Page(s) 129-133
Published Journal: Biomedica, Volume: 38, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
Diabetes mellitus, Diabetes mellitus, premalignant lesions, Hyperglycemia., Insulin-like growth factor-I, Oral
0

Citations

0

Downloads

90

Views